Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply
Lancet
.
2013 Aug 3;382(9890):395.
doi: 10.1016/S0140-6736(13)61670-0.
Authors
Cem Gabay
1
,
Arthur Kavanaugh
2
;
ADACTA investigators
Affiliations
1
University Hospitals of Geneva, Geneva, Switzerland. Electronic address: cem.gabay@hcuge.ch.
2
University of California, San Diego, La Jolla, CA, USA.
PMID:
23911377
DOI:
10.1016/S0140-6736(13)61670-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use*
Antirheumatic Agents / therapeutic use*
Arthritis, Rheumatoid / therapy*
Female
Humans
Male
Substances
Antibodies, Monoclonal, Humanized
Antirheumatic Agents